JPH1075778A5 - - Google Patents

Info

Publication number
JPH1075778A5
JPH1075778A5 JP1997181895A JP18189597A JPH1075778A5 JP H1075778 A5 JPH1075778 A5 JP H1075778A5 JP 1997181895 A JP1997181895 A JP 1997181895A JP 18189597 A JP18189597 A JP 18189597A JP H1075778 A5 JPH1075778 A5 JP H1075778A5
Authority
JP
Japan
Prior art keywords
sequence
peptide
seq
sequence type
chains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997181895A
Other languages
English (en)
Japanese (ja)
Other versions
JPH1075778A (ja
JP3978258B2 (ja
Filing date
Publication date
Priority claimed from US08/672,805 external-priority patent/US5831003A/en
Application filed filed Critical
Publication of JPH1075778A publication Critical patent/JPH1075778A/ja
Publication of JPH1075778A5 publication Critical patent/JPH1075778A5/ja
Application granted granted Critical
Publication of JP3978258B2 publication Critical patent/JP3978258B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP18189597A 1996-06-28 1997-06-24 プロトロンビンおよびトロンビンに結合するペプチド Expired - Fee Related JP3978258B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/672805 1996-06-28
US08/672,805 US5831003A (en) 1996-06-28 1996-06-28 Peptides which bind to prothrombin and thrombin

Publications (3)

Publication Number Publication Date
JPH1075778A JPH1075778A (ja) 1998-03-24
JPH1075778A5 true JPH1075778A5 (enExample) 2005-04-21
JP3978258B2 JP3978258B2 (ja) 2007-09-19

Family

ID=24700072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18189597A Expired - Fee Related JP3978258B2 (ja) 1996-06-28 1997-06-24 プロトロンビンおよびトロンビンに結合するペプチド

Country Status (10)

Country Link
US (1) US5831003A (enExample)
EP (1) EP0816377B1 (enExample)
JP (1) JP3978258B2 (enExample)
AT (1) ATE215964T1 (enExample)
AU (1) AU712575B2 (enExample)
CA (1) CA2206663A1 (enExample)
DE (1) DE69711765T2 (enExample)
DK (1) DK0816377T3 (enExample)
ES (1) ES2175218T3 (enExample)
PT (1) PT816377E (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462180B1 (en) * 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
NZ526940A (en) 2000-12-14 2005-06-24 Bayer Healthcare Llc Method of preparing alpha-1 proteinase inhibitor
GB0211849D0 (en) * 2002-05-23 2002-07-03 Mok Kenneth H Improvments to retro-inverso isomers
FR2884418B1 (fr) * 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
JP5564249B2 (ja) 2006-06-23 2014-07-30 アレシア・バイオセラピューティクス・インコーポレーテッド 癌に関与するポリヌクレオチド配列およびポリペプチド配列
AU2009321508B2 (en) 2008-11-03 2015-03-12 Adc Therapeutics Sa Antibodies that specifically block the biological activity of a tumor antigen
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
CN106146664B (zh) 2011-03-31 2021-09-07 Adc治疗股份有限公司 针对肾相关抗原1的抗体及其抗原结合片段
CA3115623A1 (en) 2012-01-09 2013-07-18 Adc Therapeutics Sa Method for treating breast cancer
ES2791982T3 (es) * 2015-02-25 2020-11-06 Omrix Biopharmaceuticals Ltd Método para purificar y cuantificar la trombina y sus polipéptidos de degradación
CA2976875A1 (en) 2015-02-25 2016-09-01 Omrix Biopharmaceuticals Ltd. Method for purifying and quantifying thrombin and its degradation polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin

Similar Documents

Publication Publication Date Title
US5594115A (en) Process of purifying recombinant proteins and compounds useful in such process
Weber Amino acid sequence studies on the tryptic peptides of the coat protein of the bacteriophage R17
Holmes et al. The protein phosphatases involved in cellular regulation: Primary structure of inhibitor‐2 from rabbit skeletal muscle
JP2002514418A5 (enExample)
JP2004000251A5 (enExample)
HUP9901069A2 (hu) Az eritropoietin receptorhoz kötődő vegyületek és peptidek
EP2327775A3 (en) Therapy for alpha-galactosidase a deficiency
DK1023080T3 (da) Ligandbindingssted af RAGE og anvendelser heraf
Sautiere et al. Primary structure of the ram (Ovis aries) protamine
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
EP1538157A3 (en) Isolation and use of SH3 binding peptides
EP2112165A3 (en) Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
WO1995009872B1 (en) Dna encoding prostaglandin receptor ip
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
Titani et al. The Amino Acid Sequence of a κ Type Bence-Jones Protein: III. The Complete Sequence and the Location of the Disulfide Bridges
CA2066913A1 (en) Novel binding peptides
CA2192467A1 (en) Calcium binding recombinant antibody against protein c
ATE322684T1 (de) Src sh3 bindende peptide und verfahren zu ihrer isolierung und verwendung
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
Biesert et al. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes: isolation and characterization of binding proteins
JP2002540769A5 (enExample)
JPH0222292A (ja) 高カルシウム体液性因子拮抗薬
AU2957099A (en) Novel physiologically active peptides and utilization thereof
Rostagno et al. Comparison of the fibrin-binding activities in the N-and C-termini of fibronectin
RU2001127439A (ru) Пептиды из последовательности Т-вируса и моноспецифические антитела, связывающиеся с ТТ-вирусом